94590-62-2

Upstream product

• 79-08-3 bromoacetic acid 
• 94590-61-1 3(R)-amino>-2,3-dihydro-1,5-benzothiazepin-4(5H)-one 
• 60115-45-9 S-(o-nitrophenyl)-L-cysteine 
• 96-32-2 bromoacetic acid methyl ester 
• 94590-59-7 2-((R)-4-Oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-ylamino)-4-phenyl-butyric acid ethyl ester 
• 95779-47-8 tert-butyl 3(R)-[1(R)-ethoxycarbonyl-3-phenylpropyl]amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-5-acetate 
• 95779-65-0 tert-butyl (R)-4-oxo-3-phthalimido-2,3,4,5-tetrahydro-1,5-benzothiazepine-5-acetate 
• 95779-67-2 tert-butyl (R)-3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-5-acetate 
• 95779-63-8 (R)-3-(2-nitrophenyl)thio-2-phthalimidopropionic acid 
• 100236-26-8 (2R)-3-(2-Aminophenylthio)-2-phthalimidopropionsaeure 
• 95779-64-9 (R)-3-phthalimido-2,3-dihydro-1,5(5H)-benzothiazepin-4-one 
• 88-74-4 2-nitro-aniline 
• 710-11-2 2-oxo-4-phenylbutyric acid 
• 2021-28-5 ethyl dihydrocinnamate 

Downstream Products

• 95779-61-6 C₂₁H₂₀N₂O₅S^(2-)*2Na⁽¹⁺⁾ 

Relevant academic research and scientific papers

Condensed, seven-membered ring compounds and their use

Novel condensed, seven-membered ring compounds of the formula: STR1 [wherein R1 and R2 each represent hydrogen, halogen, trifluoromethyl, lower alkyl or alkoxy, or both jointly form tri- or tetramethylene; R3 is hydrogen,

Angiotensin converting enzyme inhibitors: 1,5-Benzothiazepine derivatives

The synthesis of chiral 1,5-benzothiazepines 2a-c, 14a-c, 15c, and 16a prepared from cysteine is described. In vitro inhibition of angiotensin converting enzyme (ACE) is reported for each compound. Compound 2c was the most potent in vitro having an ICsub